Moreover, blocking MIF-CD74 signaling could restore the antitumor immune response against metastatic melanoma (35) and MIF inhibitors represented as a potential strategy to overcome resistance to ICB therapy in melanoma (36). The gene discussed is MIF; the disease is metastatic melanoma.